FDA Inspection 1312298 - AstraZeneca Pharmaceuticals, LP - April 03, 2026

Record Details

This FDA Inspection record concerns AstraZeneca Pharmaceuticals, LP, with an inspection on April 3, 2026, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: AstraZeneca Pharmaceuticals, LP
Inspection Date: April 3, 2026
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · f228e59d-a210-4f63-a6cd-18eed36bfcc3